Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?

touchPODCAST

touchCONGRESS for touchONCOLOGY

Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology Association (EHA) and International Society on Thrombosis and Haemostasis (ISTH) 2024 congresses on the impact and current and future management of ITP. She is joined by two additional leading ITP experts, Prof. James Bussel and Prof. Waleed Ghanima, to discuss how these data may apply in clinical practice.

Overview

• Data reviews with Dr McDonald
• Expert panel discussions with Dr McDonald, Prof. Bussel and Prof. Ghanima on the themes below

Clinical themes

1. How does ITP impact the patient and their quality of life?
2. What are the latest data that inform the use of current treatments for chronic ITP?
3. What data are there for emerging chronic ITP treatments and what do they tell us?

The internationally renowned ITP expert faculty

• Dr Vickie McDonald: London, UK
• Prof. James Bussel: New York, NY, USA,
• Prof. Waleed Ghanima: Oslo, Norway

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from Sanofi and is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our website:
https://touchoncologyime.org/itp-eha-isth-2024/